Federal contractor · WASHINGTON, DC
AMERICAN SOCIETY OF NEPHROLOGY INC
No contract obligations recorded for AMERICAN SOCIETY OF NEPHROLOGY INC in FY2026. Since FY2017: $1.9M. It also received $1.1M in federal grants and other assistance in FY2026.
- Obligations · FY2026
- $0
- New awards
- 0
- Sole-source
- —
- Single offer
- —
- UEI
- GADZZMZ1LB53
Spending by fiscal year
Obligations per federal fiscal year (October–September).
- 3.6KFY2017
- 412.5KFY2018
- 999.9KFY2019
- 500KFY2020
- 0FY2021
- 0FY2022
- -12.4KFY2023
- -30.5KFY2024
Top buying agencies
Obligations in FY2026.
No contract obligations recorded for AMERICAN SOCIETY OF NEPHROLOGY INC in FY2026.
What was bought · Where the work was performed
Obligations in FY2026.
What was bought
Where the work was performed
Integrity signals
Shares of the year's obligations, next to the country's.
Federal grants & assistance received
Grants, loans (counted at their subsidy cost), direct payments and insurance, by fiscal year of the action (USAspending.gov, FABS). Reported apart from contracts and never added to them.
AMERICAN SOCIETY OF NEPHROLOGY INC received $1.1M in federal assistance in FY2026, on 8 actions (1 new awards), +567% vs FY2025. Its largest program was 93.283 · Centers for Disease Control and Prevention Investigations and Technical Assistance ($500K).
- Assistance · FY2026
- $1.1M
- New awards
- 1
- Actions
- 8
- Since FY2021
- $4.9M
Assistance by fiscal year
- 1.3MFY2021
- 1MFY2022
- 811.5KFY2023
- 501.5KFY2024
- 160KFY2025
- 1.1MFY2026
By type
- Grants$1.1M100%
Top programs
- 93.283 · Centers for Disease Control and Prevention Investigations and Technical Assistance$500K47%
- 93.103 · Food and Drug Administration Research$300K28%
- 93.847 · Diabetes, Digestive, and Kidney Diseases Extramural Research$266.5K25%
Awarding agencies
- Department of Health and Human Services
- Food and Drug Administration$300K28%Department of Health and Human Services
- National Institutes of Health$266.5K25%Department of Health and Human Services
Largest awards
- 93.103 · Food and Drug Administration Research· Food and Drug Administration· Project grant· Jul 9, 2021 – Sep 23, 2026· R18FD005283
- 93.283 · Centers for Disease Control and Prevention Investigations and Technical Assistance· Centers for Disease Control and Prevention· Cooperative agreement· Sep 18, 2026 – Sep 18, 2026· NU50CK000660
- 93.847 · Diabetes, Digestive, and Kidney Diseases Extramural Research· National Institutes of Health· Project grant· Aug 30, 2023 – Mar 20, 2026· R25DK136141
- 93.847 · Diabetes, Digestive, and Kidney Diseases Extramural Research· National Institutes of Health· Project grant· May 2, 2025 – Jun 5, 2026· R13DK143683
Source: Federal financial assistance transactions (Financial Assistance Broker Submission) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 10, 2026, loaded Oct 10, 2026 · FY2021–FY2026.
Subawards
Matched by Unique Entity ID: the first-tier subawards this organization reported as a prime recipient, and those primes reported paying it.
As a prime: who it pays · FY2026
No subawards reported as a prime in FY2026.
As a sub-recipient: who pays it · FY2026
No subawards reported to it in FY2026.
Primes report first-tier subawards of $30,000 or more themselves, and many go unreported (GAO-24-106214). Reporting moved from FSRS to SAM.gov in March 2025 and fewer sub-contracts have been reported since. Amounts are what primes reported; they are never added to prime award totals.
Source: Subawards (first-tier sub-contracts and sub-grants reported under FFATA) (U.S. Department of the Treasury, USAspending.gov (reports filed in SAM.gov, formerly FSRS)), data current to Oct 10, 2026, loaded Oct 10, 2026 · Subawards loaded from FY2021.
Teaming partners
Companies this company reported paying, primes that reported paying it, from FFATA subaward reports.
Companies it pays
No subawards reported to other companies.
Primes that pay it
1 company · $4.2M reported
- COUNCIL OF MEDICAL SPECIA$4.2MCHICAGO, IL · 2 subawards
Primes report first-tier subawards of $30,000 or more themselves, and many go unreported (GAO-24-106214). Reporting moved from FSRS to SAM.gov in March 2025 and fewer sub-contracts have been reported since. Amounts are what primes reported; they are never added to prime award totals.
Source: Subawards (first-tier sub-contracts and sub-grants reported under FFATA) (U.S. Department of the Treasury, USAspending.gov (reports filed in SAM.gov, formerly FSRS)), data current to Oct 10, 2026, loaded Oct 10, 2026 · Subawards loaded from 2021.
Lobbying and PAC activity
Organizations in House lobbying disclosures and FEC records whose names an AI judgment matched to this company. Those records carry no identifier shared with contracts, so every match is by name.
Matched organizations
- American Society of NephrologyAI match · 100%
- Lobbying · 2025
- $290K
- 12 reports
- Lobbying · 2023–2026
- $995K
- $965K in its own reports
Lobbying by year
- 2023$185K8 reports
- 2024$350K11 reports
- 2025$290K12 reports
- 2026$170K7 reports
Top issues
- Health issues38 reports
- Science and technology20 reports
Who was contacted
- U.S. HOUSE OF REPRESENTATIVES38 reports
- U.S. SENATE38 reports
- Health & Human Services - Dept of (HHS)14 reports
- Natl Institutes of Health (NIH)11 reports
- Homeland Security - Dept of (DHS)1 reports
- Office of Management & Budget (OMB)1 reports
Houses of Congress and federal agencies the reports list as contacted (a report names every one for all its issues).
Lobbying firms hired
- JST Strategies LLC (formerly Jochum Shore & Trossevin PC)$450K15 reports
- Todd Strategy Group$360K9 reports
Registrants who are individuals are counted, not named.
Lobbying amounts are the filers' own good-faith estimates on quarterly LD-2 reports (the law asks for amounts rounded to $10,000; under $5,000 need not be itemized), latest amendment only. When an organization files its own report, it replaces what outside firms report for it that quarter. Matches are by name. Lobbying and political giving are legal and public: they show engagement with government, not influence over any award. Correlation is not influence: these organizations' lobbying and their contracts are shown side by side, and nothing here implies either affected the other.
Source: Lobbying disclosures (LD-1 registrations, LD-2 quarterly reports, LD-203 contribution reports) (Clerk of the U.S. House of Representatives), data current to Oct 10, 2026, loaded Oct 10, 2026 · 2023–2026.
Source: Committees, candidates and committee contributions to candidates (Federal Election Commission), data current to Oct 10, 2026, loaded Oct 10, 2026 · 2026, 2024, 2022.
Matches: Analisa AI name judgments (entity-match@1), updated Oct 5, 2026.
Source: Federal contract transactions (Federal Procurement Data System) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 10, 2026, loaded Oct 10, 2026.